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Abstract. Relative α-lipoic acid content of diabetic livers was considerably less than that of
normal livers as determined by gas chromatography. It was not possible to detect any
dihydrolipoic acid in the livers. Biochemical abnormalities such as hyperglycaemia, ketonemia,
reduction in liver glycogen and impaired incorporation of [2-14C] -acetate into fatty acids in
alloxan diabetic rats were brought to near normal levels by the oral or intraperitoneal
administration of dihydrolipoic acid. The effect of α-lipoic acid was comparable to that of 
dihydrolipoic acid in reducing the blood sugar levels of diabetic rabbits during a glucose 
tolerance test. 
The results suggest that the mode of action of lipoic acid was through stimulation of 
pyruvate dehydrogenase. 
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Introduction
 
α-Lipoic acid is a vital cofactor in the multienzyme complexes that catalyze the 
oxidative decarboxylation of α-keto acids (e.g., pyruvate, α-ketoglutarate and branched 
chain α-keto acids). There is an impairment of pyruvate oxidation in diabetes as 
evidenced by the decreased levels of the active form of pyruvate dehydrogenase (EC
2.4.1.1) (Kerbey et al., 1976). Consequently, a large proportion of the acetyl coenzyme A
(CoA) needed for energy generation is obtained through fatty acid oxidation resulting 
in an increased ratio of acetyl CoA/CoA in the mitochondria and increased production 
of ketone bodies (Antko, 1972; Kerbey et al., 1976; Randle et al., 1977). Further, the
increased gluconeo-genesis in diabetes has been shown to be due to enhanced activities 
of several cytosolic enzymes such as phosphoenolpyruvate carboxykinase (EC 4.1.1.32), 
fructose 1,6-bisphosphatase (EC 3.1.3.11) and the mitochondrial enzyme pyruvate 
carboxylase (EC 6.4.1.1) (Prinz and Seubert, 1964; Wilmhurst and Manchester, 1970). 
In streptozotocin induced diabetes, pyruvate carboxylase activity is significantly 
increased whereas a larger proportion of pyruvate dehydrogenase is in its inactive state 
(Weinberg and Utter, 1980). Thus, it becomes apparent that the metabolism of pyruvate 
is a crucial regulatory step in diabetes because it is a metabolite located at the crossroads 
of the three major pathways impaired in diabetes, i.e., glycolysis, gluconeogenesis and
 
 
Abbreviations used: DTO, Dihydrolipoic acid; LS2, lipoic acid; CoA, coenzyme Α; NMR, nuclear magnetic
resonance. 
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amino acid biosynthesis. Further, Wada et al. (1960) have reported that the levels of α- 
lipoic acid in the blood and liver in alloxan diabetic rats are considerably reduced. In 
view of this, it was considered useful to evaluate the role of α-lipoic acid in diabetes.
α-Lipoic acid has been estimated by several procedures including microbiological
methods (Wada et al., 1960; Herbert and Guest, 1975), gas chromatographic (Shih and
Steinsberger, 1981; White, 1981) and high performance liquid chromatography
(Howard and McCormick, 1981). The microbiological assay does not distinguish
between α-lipoic and dihydrolipoic acid and further the assay does not work in the 
presence of excess glucose. Hence, this procedure can be expected to give erroneous 
results in diabetes because of the rather high glucose concentrations. In the present 
study we have estimated the levels of α-lipoic and dihydrolipoic acid in the livers of 
normal and alloxan diabetic rats using a gas chromatographic procedure. The effect of 
α-lipoic and dihydrolipoic acid administration on some of the major biochemical 
abnormalities in diabetic rats has also been investigated. 
In this context, it may be mentioned that several investigators have attempted to 
reduce blood sugar in human diabetes by administration of α-lipoic acid (Pagliaro, 
1956; Pagliaro and Furitano, 1956; Greco, 1957; Brusa and Serafini, 1958; Zueva, 1970).
No efforts have been made to elucidate the possible mode of action of lipoic acid. In the
present study, it was found that α-lipoic acid was considerably reduced in the liver of 
diabetic rats and administration of α-lipoic and dihydrolipoic acid had a beneficial
effect on all the biochemical aberrations measured in diabetic rats.
 
 
Materials and methods
 
DL α-lipoic acid was purchased from British Drug House Ltd., Poole, England.
Alloxan monohydrate was obtained from SD Fine Chemicals, Bombay. [2-14C]-
Acetate was procured from Bhabha Atomic Research Centre, Bombay, and all other
reagents were of analytical grade. Male rats and rabbits used in this study were an
inbred Haffkine strain. 
 
Analytical methods
 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker WH 90
instrument operating under ASPECT 2000 control at 90 and 23 MHz for 1H and 13C 
respectively using CDC13 as solvent. 
For gas chromatographic analysis, methylation was carried out by reacting lipoic
acid (106mg, 0·5mmol) or dihydrolipoic acid (106mg, 0·5mmol) with anhydrous
methanolic HCl (5%, 2ml) at 60°C for 20 min. After reaction, the mixture was flushed 
with N2 gas to dryness. The methyl ester was redissolved in CHC13 for analysis.
Methylated compounds were analysed on a Hewlett Packard 5730 Α gas Chromato- 
graph. The column was 3% SP-1000 coated on Supelcoport (100–120). N2 was the 
carrier gas and the compounds were detected by flame ionization. The column
temperature was programmed from 150°-240°C at a rate of 2°C/min. The temperature
of the detector and injector were 300°C and 250°C respectively.
Lipoic acid in diabetes                                                                                        39
 
Radioactivity measurements were performed on a Packard Tricarb liquid scintil-
lation spectrometer. Blood and urinary sugar were determined according to the method
of Somogyi (1952).
 
 
Preparation and estimation of dihydrolipoic acid
 
The procedure used by Hager and Gunsalus (1953) was modified as follows: DL α- 
lipoic acid (212 mg, 1 mmol) was dissolved in 0·25 Μ potassium bicarbonate (12 ml).
Sodium borohydride (48 mg, 1·5 mmol) was added to the stirred solution keeping the
temperature below 5°C. The reaction mixture was acidified to pH 2·0 with chilled 5 Ν 
HCl and extracted with benzene. The organic layer was washed with water, dried over 
anhydrous sodium sulphate and the solvent distilled under reduced pressure.
The sulphydryl content of dihydrolipoic acid was estimated using the procedure of
Alexander (1958). 
 
 
Isolation of lipoic acid from rat liver
 
Rats of two age groups (25 and 45 days old) were used in this study. Some rats in each 
age group were made diabetic by subcutaneous injection of alloxan (180 mg/kg) in
acetate buffer (0·1 M, pH 5·4). Rats excreting more than 10 g/1 sugar in urine were used
in the study. 
α-Lipoic acid was isolated from the livers of rats as described by Carreau (1979).
Normal and diabetic rats (4 each in the two age groups) were sacrificed, the livers 
removed, washed with saline, blotted dry and weighed. Wet liver (1g) was homogenized 
in Potter-Elvehjem homogenizer with 7 ml of water at 4°C. Homogenization was 
continued first with the addition of 17 ml methanol followed by 17 ml chloroform and 
finally 8 ml of water. The resulting mixture was centrifuged at 2000g at 0°C for 20 min. 
Three layers separated: (i) upper aqueous methanolic layer, (ii) interphase and 
(iii) lower chloroform layer. The layers were separated, the interphase was homogen- 
ized with a 2:1 mixture of water and chloroform and centrifuged as before. The 
aqueous and chloroform layers were separated and mixed with the corresponding 
layers from the first centrifugation. This operation was repeated four more times.
The pooled aqueous methanolic extracts were concentrated on a rotary evaporator 
and the residue was dissolved in 0·5 ml of 6 Ν HCl and hydrolyzed in a sealed tube at
110°C for 16 h. After evaporating the HCl, the residue was extracted with chloroform. 
The chloroform layer was evaporated with a stream of N2 gas and the lipoic acids were 
separated on thin layer chromatography with chloroform: methanol:water:formic 
acid (75:25:4:1;v/v). Pure lipoic and dihydrolipoic acid (visualised on a separate plate  
with a solution of 0·5g of palladium chloride, 100ml water, 400ml ethanol and 10 
drops of cone. HCl) regions were cut out, extracted with chloroform: methanol (1:1, 
v/v). The extract was filtered, the solvent evaporated and the residue esterified with 
methanolic HCl. 
The methylated compounds were filtered through a microcolumn (0·5×3cm) of
silicic acid (100 mesh) and the samples used for gas chromatography.
40 Natraj et al.
 
Glucose tolerance test in normal and diabetic rabbits
 
Four normal and six alloxan diabetic rabbits weighing about 2·5kg were starved for 
18h and their fasting blood sugar determined. Dihydrolipoic acid or α-lipoic acid
(l00µmol/kg) was injected intraperitoneally as a suspension in 0·5ml of 0·8% saline 
in two normal and three alloxan diabetic rabbits. The remaining animals received 0·5ml
of saline alone. Two h later a 40% solution of glucose in water (2g/kg) was administered
orally. Blood sugar (ear vein) was estimated at hourly intervals upto 4 h.
 
Blood sugar in diabetic rats
 
Nine alloxan diabetic rats weighing about 100g were divided into two groups.
Dihydrolipoic acid (500 µmol/kg) was administered orally as a suspension in saline in
six animals and three animals receiving saline alone served as controls. Blood was
drawn by cardiac puncture at 0,2 and 4h following dihydrolipoic acid administration 
and the sugar content determined. 
 
Acetoacetate levels in diabetic rats
 
Dihydrolipoic acid (500µmol/kg) was administered as a suspension in saline to four
alloxan diabetic rats. Blood was collected by cardiac puncture before and 24 h after
dihydrolipoic acid administration and acetoacetate was estimated by the method of
Walker (1954).
 
Liver glycogen in normal and diabetic rats
 
Six normal and 6 alloxan diabetic rats weighing about 100g were distributed into two
groups. Dihydrolipoic acid (500µmol/kg) as a suspension in saline was injected
intraperitoneally to three normal and three diabetic rats. The remaining animals were
injected saline alone. The animals were sacrificed 24h later, the livers removed, washed
with a solution of saline, blotted dry and weighed. The glycogen content was
determined according to the method of Hassid and Abraham (1956).
 
[2-l4C] -Acetate incorporation into liver lipids in normal and diabetic rats
 
Dihydrolipoic acid (500µmol/kg) was injected intraperitoneally into three normal and
four diabetic rats. Three normal and 4 diabetic rats administered saline only served as
controls. Two h later [2-14C]-acetate (4µCi/100) g) was injected in all the animals.
Twenty four h after dihydrolipoic acid administration, the animals were sacrified, the
livers removed, washed with a solution of saline, blotted dry and weighed. The wet livers
were homogenized in chloroform: methanol (2:1 v/v) in an Omnimixer for 5 min at
3000 rpm. The organic layer was separated by filtration, washed with a 0·03%
magnesium chloride solution and then with water. The solvent was distilled under
reduced pressure and the residue (lipids) was weighed to a constant weight. The total
radioactivity in the residue was determined.
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Results
 
GC analysis of methyl lipoate and methyl dihydrolipoate
 
Methyl lipoate gave a single peak with a retention time of 32·9 min (figure 1, panel A). 
However, methyl dihydrolipoate gave two peaks with retention times of 28·4 and 32·9 
min (figure 1, panel B). The relative intensities of these two peaks were 40:56. The latter 
corresponds to methyl lipoate and the former presumably to methyl dihydrolipoate. It
was therefore necessary to establish whether the methyl dihydrolipoate was con-
taminated with methyl lipoate or whether during GC analysis it was getting oxidized to 
methyl lipoate. Purity analysis was carried out using 13C NMR. From this analysis it
was concluded that methyl dihydrolipoate was 95% pure. Therefore, it appears that
during GC analysis 56% of the methyl dihydrolipoate gets oxidized. As long as the
extent of this reaction is taken into account, GC analysis of liver samples can be used for
quantitative estimation of dihydrolipoic acid levels.
 
Levels of α-lipoic and dihydrolipoic acid in rat livers
 
The presence of α-lipoic acid was detected in all the liver samples tested by this method.
Despite the presence of unidentified peaks in the gas chromatogram, α-lipoic acid could
be identified as a distinct peak with a retention time of 32 min (figure 1, panel C).
Inclusion of a known quantity of methyl lipoate as an external standard showed that
the intensity of the peak with a retention time of 32 min was increased by the 
corresponding amount (figure 1, panel D). The relative peak areas before and after 
addition of standard methyl lipoate was a measure of the lipoic acid content in the 
sample (table 1). In alloxan diabetic rat livers the α-lipoic acid content was one fourth of
that found in normal livers. 
Dihydrolipoic acid could not, however, be detected in any of the samples analysed.
Taking into account the sensitivity of this method, it was estimated that the levels of
dihydrolipoic acid, if present, must be less than 0·5 µg/g tissue.
The results of the glucose tolerance test are shown in table 2. Dihydrolipoic acid and
 
 
Figure 1. Gas chromatography analysis of methyl lipoate and methyl dihydrolipoate. Panel
A, Pure methyl lipoate (a). Panel B, Methyl dihydrolipoate. Panel C, Liver extract. Panel D,
Same extract with externally added methyl lipoate.
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Table 1. α-Lipoic acid content of livers from normal 
and alloxan diabetic rats. 
 
 
All values are means of 4 rats ± S.E
 
 
Table 2. Glucose tolerance test in normal and diabetic rabbits.
 
 
Numbers in parenthesis indicate the number of animals. 
 
 
α-lipoic acid administration in alloxan diabetic rabbits brought about a significant
reduction in the blood sugar levels in a paired ‘t’ test at all the time points tested.
Furthermore, the profile of the glucose tolerance test resembled the normal profile
more closely. Neither dihydrolipoic acid nor α-lipoic acid had any significant effect on
blood glucose levels in normal rabbits. 
Similarly, it was found that dihydrolipoic acid administered orally also brings about
a significant reduction in the blood sugar levels of diabetic rats (table 3). The mean 
reduction in the blood sugar levels at the end of 2 and 4h was 22% and 38%
respectively. 
Acetoacetate levels in the blood were reduced by a greater than two fold margin
following dihydrolipoic acid administration in diabetic rats (table 4).
In addition to bringing about a reduction in the blood sugar and acetoacetate levels
in diabetic rats, dihydrolipoic acid increases the liver glycogen (table 5) and [2-14C]-
acetate incorporation into liver lipids (table 6) by a greater than two fold margin. At the
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Table 3.  Blood glucose levels in diabetic rats.
 
 
Numbers in parenthesis indicate the number of animals.
* Not significantly different from 0 h reading. 
** Significantly different from 0 h reading at Ρ < 0·1.
*** Significantly different from 0 h reading at Ρ < 0·01.
 
Table 4.  Acetoacetate levels in blood of diabetic rats.
 
All values are means of 4 animals ± SE. 
 
Table 5.   Liver glycogen in normal and diabetic rats.
 
 
All values are means of 3 animals ± S E.
? Not significant.
 
same time, these two constituents are not affected significantly in normal rats
administered dihydrolipoic acid.
 
Discussion 
 
It is evident that α-lipoic acid levels are significantly reduced in rat livers during alloxan
diabetes. Wada et al. (1960) had noted a similar reduction in α-lipoic acid in diabetic
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Table 6. Incorporation of [2_14C]-acetate into liver lipids.
 
 
Numbers in parenthesis indicate the number of animals ± SE.
* Not significance. 
 
 
rats. However, they had employed the microbiological assay which has several
limitations as pointed out earlier. We have also shown that dihydrolipoic acid could not
be detected in the livers of normal or alloxan diabetic rats. It is interesting to note that 
Shih and Steinsberger (1981) employing a similar extraction followed by GC analysis
also failed to detect any dihydrolipoic acid in chick liver. It appears reasonable to
conclude therefore, that α-lipoic acid exists mainly as the disulphide and not the 
sulphydryl form in liver. 
Lipoic acid exists predominantly in the protein bound form as the ε-aminolysyl 
amide (Reed, 1966). The method of extraction employed in this study is designed to 
measure only protein bound lipoic acid. It is, of course, possible that some of the α- 
lipoic acid may be degraded during acid hydrolysis. However, it is expected that this loss 
does not affect the ratio of α-lipoic acid levels in normal and alloxan diabetic rat livers.
Results of α-lipoic and dihydrolipoic acid administration show that the four major
biochemical abnormalities in diabetes viz., hyperglycaemia, ketonemia, reduced
glycogen and fat synthesis, have been corrected to a significant extent by the
administration of dihydrolipoic acid in diabetic rats. On the other hand, dihydrolipoic
acid did not affect any of these parameters to a significant extent in normal animals. In
addition, dihydrolipoic acid increases the tolerance to glucose in diabetic rabbits during
a glucose tolerance test. In this system the effect of α-lipoic acid is very similar to that of 
dihydrolipoic acid. 
Diabetes is a disease characterised by an aberration of glucose metabolism and 
transport (Foster, 1978; Karnielli et al., 1981). Insulin administration has a general 
beneficial effect on both these parameters. It is difficult to assess the relative 
contributions made by these two effects in diabetes because of the difficulty in studying
them in isolation. However, it is safe to say that both effects are extremely important for 
the proper management of glucose levels in the blood. The mechanism of action of 
insulin in improving glucose metabolism has been ascribed generally to the stimulation
of several enzymes involved in glycolysis, tricarboxylic acid cycle and fatty acid
biosynthesis (Denton et al., 1981). The pivotal enzyme at the crossroads of these three
pathways is pyruvate dehydrogenase (EC 1.2.4.1) which is a multienzyme complex
catalyzing the oxidative decarboxylation of pyruvate to acetyl CoA. In view of the
<, 
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importance of this reaction in the metabolism of glucose, the role of insulin in
regulating the activity of this enzyme is of considerable interest.
The predominant mode of regulation of pyruvate dehydrogenase has been shown to 
be by a phosphorylation (inactive enzyme) and dephosphorylation (active enzyme) 
mechanism. Insulin brings about a reversible dephosphorylation, thus converting the
inactive to the active form (Hughes et al., 1980). The importance of the activation of
pyruvate dehydrogenase in mediating the hypoglycaemic effect of insulin is evidenced
by the fact that dichloroacetate, an inhibitor of pyruvate dehydrogenase kinase also
brings about an activation of pyruvate dehydrogenase, and has been shown to induce
hypoglycaemia in diabetic and starved normal rats (Whitehouse and Randle, 1973; 
Blackshear et al., 1974). Thus, one may presume that atleast a part of the hypoglycaemic 
effect of insulin is mediated by the activation of pyruvate dehydrogenase. 
The question, therefore, is whether the beneficial effects of dihydrolipoic acid and α- 
lipoic acid administration in diabetes is mediated through insulin secretion or directly 
through the activation of pyruvate dehydrogenase. Since alloxan administration results 
in a near total destruction of β-cells of the pancreas, neither α-lipoic or dihydrolipoic 
acid release any extra insulin over and above that released by the high glucose levels 
present in diabetic rats (Malaisse et al., 1982). 
Evidence for the alternative hypothesis stems from the fact that the activity of 
pyruvate dehydrogenase is lowered in alloxan diabetes (Kerbey et al., 1976).
Administration of insulin restores only a part of the activity of this enzyme (Stansbie et 
al.,1980; Wieland et al., 1971). This points to an irreversible diminution of a part of this 
enzyme activity in alloxan diabetic rats, perhaps due to lower levels of α-lipoic acid in 
the liver. It would be reasonable to conclude therefore, that administration of α-lipoic 
acid or dihydrolipoic acid restores the activity of this enzyme thus alleviating some of
the biochemical aberrations in diabetes. Definitive evidence indicating the enhancing
effect of lipoic acid on liver pyruvate dehydrogenase Bill be presented in a subsequent
communication.
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